All In MedTech

Device Trial Radar · NCT02926209

Post Market Evaluation of Aer-O-Scope Visualization

Last checked: Nov 20, 2026Latest source record: Jul 16, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingRandomized with 104 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

104

Actual

Start

Feb 21, 2017

Primary completion

Nov 8, 2017

Study completion Apr 11, 2018

Sponsor

Lead sponsor
GI View Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Oct 6, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Screening
FDA-regulated device
Yes
Who can join
All sexes, from 45 years, up to 75 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This will be a prospective multi-center, multi-national comparative non-blinded clinical investigation. Each subject will undergo back-to-back tandem colonoscopies with the Aer-O-Scope Colonoscope System and a conventional colonoscope since this is a tandem colonoscopy study, each subject will serve as their own control. The 1st procedure will be randomized, half to Aer-O-Scope Colonoscope System and half to conventional colonoscope. The same investigator will perform both procedures on each subject. All pathologies found will be either removed or tattooed. Unmarked pathologies found on second pass will represent those missed during the 1st pass, thus making the subject and the control one and the same. Tattooed pathologies that can be removed endoscopically will be removed in an additional colonoscopy. This may occur if a large polyp cannot be removed for any reason with the Aer-O-Scope, but can be removed with conventional colonoscopy.

Conditions

  • Cancer

Interventions

  • Aer-O-Scope (Colonoscopy)Device

    Patients in the "Aer-O-Scope first arm" will undergo a colonoscopy with the Aer-O-Scope, removing any polyps detected, followed by a colonoscopy using a conventional colonoscope, removing any polyps not previously detected with the Aer-O-Scope.

  • Colonoscopy (Conventional Colonoscope)Procedure

    Patients in the "conventional colonoscope first arm" will undergo a colonoscopy with a conventional colonoscope, removing any polyps detected, followed by a colonoscopy using the Aer-O-Scope, removing any polyps not previously detected with the conventional colonoscope

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adenoma Miss RatesTime frame: Through study completion, an average of one year

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • Waldron Endoscopy Center

    Tacoma, Washington

  • Tel Aviv Souraski Medical Center

    Tel Aviv, Israel

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.